Evidence level: B
韩国人用孟德尔随机化证明”太阴体质升高、少阴体质降低心源性栓塞卒中风险”,这条因果链搬到中国痰湿体质上是否还能成立?复现失败时,到底该怪”太阴≠痰湿”的映射,还是怪”体质 GWAS 太小”的功效?本文把这场裁决设计成可以执行的实验方案。
正文
四象医学的”太阴体质”和中医九种体质的”痰湿体质”,常被学界当成同一种东西的两种叫法:都指向腹型肥胖、血脂异常、代谢紊乱的高危人群。2024 年韩国韩医学研究院用孟德尔随机化(MR)给四象体质与卒中亚型做了因果推断,发现携带太阴体质相关遗传信号的个体,心源性栓塞性卒中(cardioembolic stroke, CES)风险显著升高(β=4.190, p=0.035);而少阴体质的信号则显著降低该风险(β=−9.336, p=3.87×10⁻⁵)(PMID 38927518)。这是”某种体质更容易得某类中风”第一次拿到因果级证据——但它来自韩国体系、韩国人群、韩国样本。问题随之而来:这条因果链在中国痰湿体质上复现吗?
复现实验有三个零件。 第一件是暴露侧:中国痰湿体质的 GWAS 汇总统计量。这是整场实验最薄弱的一环——目前公开的中医体质 GWAS 样本量仅千人级,而痰湿体质的基因组学研究仍停留在”4 个上调、6 个下调基因”的候选基因阶段(PMID 23548117),远没到全基因组显著位点批量涌现的程度。第二件是结局侧:卒中 GWAS。这一侧反而是强项——MEGASTROKE 跨国联盟贡献了 52 万人的多祖先荟萃分析,确认了 32 个卒中风险位点,其中 PITX2、ZFHX3 两个位点特异性地与心源性栓塞亚型关联(PMID 29531354);2022 年 GIGASTROKE 进一步把规模推到 110,182 例卒中、150 万对照,覆盖五种祖先,东亚人群单独就有 27,413 例病例,CES 亚型位点达到 13 个(PMID 36180795)。结局数据的功效绰绰有余。第三件是裁决方法:双样本 MR 加功效分析。
为什么必须预先算功效,而不是跑完再看? 因为”复现失败”有两种截然不同的含义:太阴与痰湿在生物学上根本不对应(映射错误),或者痰湿体质 GWAS 太小、工具变量太弱、统计功效不足以检测出真实效应(功效不足)。两者在数据上长得一模一样——都是”效应不显著”。区分它们的唯一办法,是在实验设计阶段就把”在给定体质 GWAS 样本量和工具强度下,能检测到多大效应”算清楚。MR 功效取决于三个参数:工具变量解释的暴露方差比例、真实验应大小、样本量;已有成熟的公式和在线计算器(PMID 24159078),多工具变量、两样本共享样本等复杂场景也有推广公式(PMID 32048336)。韩国研究自己的体质 GWAS 只有 5797 人,工具强度本来就有限——如果中国体质 GWAS 连这个规模都达不到,那么”复现失败”的第一嫌疑就是功效不足,而不是映射错误。
裁决逻辑树应当这样设计。 第一步,用痰湿体质 GWAS 的独立工具变量(F>10、LD 修剪)对 CES 结局(MEGASTROKE 欧洲或 GIGASTROKE 东亚子集)跑双样本 MR,记录效应方向与量级;第二步,与 PMID 38927518 的太阴结果对比——方向同为正向且置信区间交叠,判”跨体系复现成功”,这是最强的结果,说明两套体质分类在脑血管风险维度上捕捉到了同一组遗传-代谢因果通路;第三步,若方向不一致或效应量级差一个数量级,启动归因程序:先做功效计算,若在现有样本量下预期能检测的效应下限(如 β=4.19 对应 80% 功效所需样本)远小于实际样本量,判定”功效不足”,结论是”待更大体质 GWAS 再裁”;反之若功效充足仍不显著,判定”映射错误”,结论是”太阴与痰湿在 CES 因果链上并不同构”。
这场裁决的科学价值不取决于输赢。 复现成功,说明中医体质学与四象医学共享可遗传的脑血管风险底层,为”体质分类是同构的”提供遗传学证据;复现失败且归因于功效不足,说明中医体质遗传学缺的不是理论而是样本,推动体质 GWAS 向万人级迈进;复现失败且归因于映射错误,则提醒学界”太阴≈痰湿”的表型相似不能自动外推为遗传同构。三种结局都推进认知——这正是跨体系复现实验的意义所在。而所有结论成立的前提,是实验设计阶段就把功效预算写进方案,否则”不显著”永远是一笔糊涂账。
证据与局限
已验证: 韩国四象体质 MR:太阴↑CES(β=4.190, p=0.035)、少阴↓CES(β=−9.336, p=3.87×10⁻⁵)(PMID 38927518);MEGASTROKE 确认 PITX2/ZFHX3 与 CES 亚型特异关联(PMID 29531354);GIGASTROKE 跨祖先荟萃含东亚 27,413 例卒中,CES 位点 13 个(PMID 36180795);MR 功效计算公式与在线工具已发表(PMID 24159078, 32048336)。
部分验证: 痰湿体质与代谢紊乱的关联有基因组学支持(4 上 6 下调基因,易感高脂血症/糖尿病)(PMID 23548117),但痰湿体质尚无公开的万人级 GWAS 汇总统计量,是复现实验当前的实际瓶颈。
待验证: ① 痰湿体质 GWAS 位点与 CES 的双样本 MR 效应方向/量级能否与韩国太阴结果对齐;② 复现失败时,”映射错误”与”功效不足”的归因判定;③ 少阴的 CES 保护效应(β=−9.336)在中医阳虚/阴虚/气虚三类体质中的对应甄别。
相关阅读
证据等级: B
参考文献: PMID 38927518, PMID 29531354, PMID 36180795, PMID 23548117, PMID 24159078, PMID 32048336
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Can Phlegm-Damp Constitution Reproduce the \”Cardioembolic Stroke\” Causal Chain of Taiyin: Designing a Verdict for Cross-Population Replication Experiments
Evidence level: B
Koreans used Mendelian Randomization (MR) to demonstrate that “Taiyin constitution increases and Shaoyin constitution decreases the risk of cardioembolic stroke.” Does this causal chain hold when transplanted to the Chinese Phlegm-Dampness constitution? If replication fails, should we blame the mapping error (“Taiyin ≠ Phlegm-Dampness”) or the low power of the “Constitution GWAS”? This article designs this adjudication as an executable experimental protocol.
Main Text
The “Taiyin constitution” of Four-Temperatures Medicine and the “Phlegm-Dampness constitution” of Traditional Chinese Medicine (TCM) are often treated by the academic community as two names for the same entity: both point to high-risk populations characterized by abdominal obesity, lipid abnormalities, and metabolic disorders. In 2024, the Korean Academy of Traditional Korean Medicine used Mendelian Randomization (MR) to infer causality between Four-Temperatures constitutions and stroke subtypes, finding that individuals carrying genetic signals associated with Taiyin constitution had a significantly elevated risk of cardioembolic stroke (CES) ($\beta=4.190, p=0.035$), while Shaoyin constitution signals significantly reduced this risk ($\beta=-9.336, p=3.87\times10^{-5}$) (PMID 38927518). This represents the first causal-level evidence for “a specific constitution predisposing to a certain type of stroke”—yet it originates from the Korean system, Korean population, and Korean samples. The question arises: Does this causal chain replicate in the Chinese Phlegm-Dampness constitution?
Replication requires three components. The first is the exposure side: summary statistics from the GWAS of Phlegm-Dampness constitution. This is the weakest link in the entire experiment—currently, public TCM constitution GWAS sample sizes are only in the thousands, and research on Phlegm-Dampness constitution remains at the candidate gene stage (“4 upregulated, 6 downregulated genes”) (PMID 23548117), far from the point where genome-wide significant loci begin to emerge in bulk. The second is the outcome side: stroke GWAS. This side is actually a strength—the MEGASTROKE consortium contributed a multi-ancestry meta-analysis of 520,000 individuals, confirming 32 stroke risk loci, two of which (PITX2, ZFHX3) are specifically associated with the cardioembolic subtype (PMID 29531354); GIGASTROKE further expanded the scale to 110,182 stroke cases and 1.5 million controls across five ancestries, with 27,413 cases in East Asians alone and 13 loci reaching significance for the CES subtype (PMID 36180795). The statistical power regarding outcome data is more than sufficient. The third is the adjudication method: two-sample MR combined with power analysis.
Why must power be calculated in advance rather than after running the analysis? Because “replication failure” has two distinctly different meanings: either Taiyin and Phlegm-Dampness are fundamentally non-corresponding biologically (mapping error), or the Phlegm-Dampness GWAS is too small, the instrumental variables are too weak, and statistical power is insufficient to detect a true effect (power deficiency). Both look identical in the data—”non-significant effect.” The only way to distinguish them is to calculate beforehand, during the experimental design phase, “what magnitude of effect can be detected given a specific constitution GWAS sample size and instrument strength.” MR power depends on three parameters: the proportion of exposure variance explained by instrumental variables, the true effect size, and sample size; mature formulas and online calculators exist (PMID 24159078), with generalized formulas for complex scenarios involving multiple instruments and shared samples (PMID 32048336). The Korean study itself had a constitution GWAS of only 5,797 individuals, limiting instrument strength inherently. If the Chinese constitution GWAS fails to even reach this scale, then the first suspicion for “replication failure” must be power deficiency, not mapping error.
The adjudication logic tree should be designed as follows. Step 1: Run two-sample MR using independent instrumental variables (F>10, LD pruning) from the Phlegm-Dampness constitution GWAS against the CES outcome (MEGASTROKE European subset or GIGASTROKE East Asian subset), recording effect direction and magnitude. Step 2: Compare with the Taiyin results from PMID 38927518—directions are positive and confidence intervals overlap, judging “cross-system replication success.” This is the strongest result, indicating that both constitution classification systems capture the same group of genetic-metabolic causal pathways regarding cerebrovascular risk. Step 3: If directions are inconsistent or effect magnitudes differ by an order of magnitude, initiate the attribution procedure: first perform power calculation. If the expected lower bound of detectable effect under current sample size (e.g., sample size required for 80% power corresponding to $\beta=4.19$) is far smaller than the actual sample size, judge “power deficiency,” concluding “await larger constitution GWAS for further adjudication”; conversely, if power is sufficient yet still non-significant, judge “mapping error,” concluding “Taiyin and Phlegm-Dampness are not isomorphic in the CES causal chain.”
The scientific value of this adjudication does not depend on winning or losing. Successful replication indicates that TCM constitution science and Four-Temperatures Medicine share an underlying heritable genetic basis for cerebrovascular risk, providing genetic evidence that “constitution classification is isomorphic.” Failure attributed to power deficiency indicates that TCM constitution genetics lacks not theory but sample size, pushing constitution GWAS toward the ten-thousand-person scale. Failure attributed to mapping error then reminds the academic community that phenotypic similarity (“Taiyin ≈ Phlegm-Dampness”) cannot be automatically extrapolated to genetic isomorphism. All three outcomes advance cognition—this is precisely the significance of cross-system replication experiments. The prerequisite for all conclusions to hold is that power budgets are written into the protocol during the experimental design phase; otherwise, “non-significance” remains an accounting糊涂账 (a confusing ledger).
Evidence and Limitations
Verified: Korean Four-Temperatures MR: Taiyin↑CES ($\beta=4.190, p=0.035$), Shaoyin↓CES ($\beta=-9.336, p=3.87\times10^{-5}$) (PMID 38927518); MEGASTROKE confirmed specific association of PITX2/ZFHX3 with CES subtype (PMID 29531354); GIGASTROKE cross-ancestry meta-analysis includes 27,413 East Asian stroke cases with 13 CES loci (PMID 36180795); MR power formulas and online tools are published (PMID 24159078, 32048336).
Partially Verified: Association between Phlegm-Dampness constitution and metabolic disorders has genomic support (4 up, 6 down genes, predisposing to hyperlipidemia/diabetes) (PMID 23548117), but no public ten-thousand-person-level GWAS summary statistics exist for Phlegm-Dampness constitution, representing the current practical bottleneck for replication.
To Be Verified: ① Can the two-sample MR effect direction/magnitude of Phlegm-Dampness GWAS loci align with Korean Taiyin results regarding CES; ② Attribution judgment between “mapping error” and “power deficiency” upon replication failure; ③ Discrimination of corresponding constitutions in TCM Yang Deficiency/Yin Deficiency/Qi Deficiency categories for the protective CES effect of Shaoyin ($\beta=-9.336$).
Related Reading
- Can Mendelian Randomization Results for Four-Temperatures Constitution Be Replicated Across Systems in TCM Nine Constitutions
- Proportion of Pleiotropy Contamination in Constitution Loci
- Audit of Instrument Strength for TCM Nine Constitutions GWAS
- Research Pool for Biological Frequency Codes
Evidence Level: B
References: PMID 38927518, PMID 29531354, PMID 36180795, PMID 23548117, PMID 24159078, PMID 32048336
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply